Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating nalmefene for reducing alcohol consumption in adults with alcohol dependence; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Nalmefene (nalmefene)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Alcohol Dependence | Phase 3 | Status: COMPLETED | Results posted: 2019-09-30